These projects were made possible from Cure Alzheimer's Fund support.
| Project Description | Researchers | Funding |
|---|---|---|
| Role of Platelet-Derived Factors in Ameliorating Alzheimer’s Disease Pathology |
2025 $201,250 |
|
| Role of the Circulating Exerkine GPLD1 in Ameliorating Alzheimer’s Disease Pathology |
2022, 2024 $402,500 |
These published papers resulted from Cure Alzheimer’s Fund support.
Bieri, G., Pratt, K. J. B., Fuseya, Y., Aghayev, T., Sucharov, J., ... Yang, A. C., Casaletto, K. B., & Villeda, S. A. Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature, Cell, February 28, 2026, Read More